Historical Lessons
- GI Endoscopy: Structural migration from hospital to ASC is now the standard site-of-service for routine diagnostic and therapeutic procedures.
- Cardiac Cath: Historical precedent shows high-volume procedural lines inevitably follow structural reimbursement incentives toward lower-cost settings.
Why EP is Different
Structural Urgency
The site-of-service shift for cardiac ablation is not hypothetical. Effective January 1, 2026, CMS policy creates a mandatory structural decision point for HCA health systems.
THE DEFENSIVE MOAT — PATTERN RECOGNITION
We have seen this movie. Twice.
GI endoscopy and cardiac catheterization both followed predictable trajectories after CMS opened the ASC site. The first 18–24 months determined who controlled the resulting market — hospital systems that moved early, or physician-owned and PE-backed ASCs that captured the volume and the referral chain. EP is now at month zero.
GI Endoscopy
Hospitals lost the line
Before the structural shift hit the P&L, physician-owned and PE-backed centers had already seized the volume, referral networks, and long-term GI economics.
Cardiac Cath
Early movers preserved share
Early adopters of ASC joint ventures and specialist alignment secured superior case mix and long-term cardiology market share.
EP Ablation
The window is now
Higher-margin EP economics and PFA’s rapid ASC volume acceleration make the first 18–24 months critical to securing your decade-long market position.
STRATEGIC CADENCE
The EP Ablation Strategic Framework
FOUNDERS
Leadership Team
Ian Roy
Co-Founder / CEO
20-year U.S. Navy SEAL Officer with extensive leadership experience across Naval Special Warfare, serving in complex and demanding operational environments worldwide. He has worked alongside innovative technology companies, including supporting the early growth efforts of Shield AI and Ametrine, contributing to strategic development initiatives during their formative stages. Ian's background combines operational leadership, team building, and experience helping organizations translate emerging technologies into real-world impact.
Jack Brodowicz
Co-Founder / COO
Former U.S. Navy SEAL Officer and graduate of the United States Naval Academy, where he was a multi-sport Division I athlete. Served in multiple leadership roles within Naval Special Warfare, including as Operations Officer responsible for planning and executing mission sets across a large geographic theater in support of a special operations task force. Led cross-functional teams, coordinated interagency efforts, and managed complex operational architectures in high-stakes environments.
Dr. Antony Chu, MD / MBA
Co-Founder / CMO · Cardiologist
Yale / MIT-trained clinical cardiac electrophysiologist operating at the intersection of clinical medicine, engineering, and AI. Internationally recognized expert in bioelectric cardiac signal processing, complex ablation, and machine-learning-enabled clinical decision systems. Has led development of platforms integrating continuous biometric data, wearable sensors, and predictive algorithms for real-time risk stratification. Underpins Sovryn’s vision of multi-agent, data-integrated intelligence for human performance and disease forecasting.
PARTNERs
Sovryn Group's partnership with Medtech Incubator enhances the electrophysiology healthcare supply chain by combining clinical expertise with proven commercialization, logistics, and operational infrastructure. Through access to inventory management, procedural logistics, physician engagement networks, recruitment resources, financial operations, and healthcare market intelligence, the partnership helps hospitals, ASCs, and industry stakeholders streamline operations, accelerate the adoption of innovative cardiovascular technologies, and improve patient access to advanced therapies. This integrated model reduces friction across the care continuum while creating a scalable framework for growth, efficiency, and long-term value creation within the electrophysiology ecosystem.